rs104886431
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_033380.3(COL4A5):c.547-1G>A variant causes a splice acceptor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_033380.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- Alport syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen, G2P
- X-linked Alport syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL4A5 | ENST00000328300.11 | c.547-1G>A | splice_acceptor_variant, intron_variant | Intron 9 of 52 | 1 | NM_033380.3 | ENSP00000331902.7 | |||
| COL4A5 | ENST00000361603.7 | c.547-1G>A | splice_acceptor_variant, intron_variant | Intron 9 of 50 | 2 | ENSP00000354505.2 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1051761Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 327059
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This sequence change affects an acceptor splice site in intron 9 of the COL4A5 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in COL4A5 are known to be pathogenic (PMID: 9195222, 10752524, 14514738, 24854265, 26809805). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with Alport syndrome (PMID: 11462238, 20378821). This variant is also known as c.749-1G>A. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
X-linked Alport syndrome Pathogenic:1
DNA sequencing revealed a novel hemizygous splicing mutation, NM_000495: c.547-1G>A, in three males from a Tunisian family. This splicing mutation, NM_000495: c.547-1G>A, was not found in the NHLBI Exome Variant Server or the ClinVar database. Analysis of NM_000495: c.547-1G>A using Alamut predicted a highly probable exon 10 skipping. The segregation pattern is consistent with an X-linked dominant mode. Notably, this novel mutation was absent in 50 control Tunisian samples. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at